Cargando…
Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734426/ https://www.ncbi.nlm.nih.gov/pubmed/30823868 http://dx.doi.org/10.1186/s10194-019-0975-2 |
| _version_ | 1783450147825385472 |
|---|---|
| author | Nichols, Russell Skljarevski, Vladimir Dell’Agnello, Grazia Hundemer, Hans-Peter Aurora, Sheena K. |
| author_facet | Nichols, Russell Skljarevski, Vladimir Dell’Agnello, Grazia Hundemer, Hans-Peter Aurora, Sheena K. |
| author_sort | Nichols, Russell |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6734426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67344262019-09-12 Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention Nichols, Russell Skljarevski, Vladimir Dell’Agnello, Grazia Hundemer, Hans-Peter Aurora, Sheena K. J Headache Pain Letter to the Editor Springer Milan 2019-03-01 /pmc/articles/PMC6734426/ /pubmed/30823868 http://dx.doi.org/10.1186/s10194-019-0975-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Nichols, Russell Skljarevski, Vladimir Dell’Agnello, Grazia Hundemer, Hans-Peter Aurora, Sheena K. Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title | Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title_full | Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title_fullStr | Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title_full_unstemmed | Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title_short | Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| title_sort | letter to the editor regarding european headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734426/ https://www.ncbi.nlm.nih.gov/pubmed/30823868 http://dx.doi.org/10.1186/s10194-019-0975-2 |
| work_keys_str_mv | AT nicholsrussell lettertotheeditorregardingeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention AT skljarevskivladimir lettertotheeditorregardingeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention AT dellagnellograzia lettertotheeditorregardingeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention AT hundemerhanspeter lettertotheeditorregardingeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention AT aurorasheenak lettertotheeditorregardingeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention |